5mg | Tablets
The Reimbursement Solution TerugBetaalRegeling (TBR) of Xigduo (dapagliflozine & metformine HCI) 5 mg for patients with diabetes type 2, WITHOUT a very high risk of cardiovascular disease AND who are not eligible for the pre-existing reimbursement of the health insurer (combination with metformin and/or SU), will be continued. The end date for this TBR for this group of patients has not yet been determined.
Type 2 diabetes patients WITH a very high risk on cardiovascular disease are covered by the regular reimbursement of the health insurance. Very high risk is defined as:
• established cardiovascular disease; and/or
• chronic kidney disease with
− eGFR 30-44 ml/min/1,73 m2 without albuminuria or
− eGFR 30-59 ml/min per 1.73m2 with moderately elevated albuminuria (ACR > 3 mg/mmol/l); or
− eGFR ≥ 60 ml/min per 1.73 m2 with severely elevated albuminuria (ACR > 30 mg/mmol)
(NL-8749 Prod 02.2022)
For a complete reimbursment overview of Forxiga® (dapagliflozine) 10 mg/Xigduo 5 mg, click here.
For a digital reimbursement guide of Forxiga® (dapagliflozine) 10 mg/Xigduo 5 mg, click here.
|Dose||Xigduo® 5mg and Forxiga® 10mg|
|Active ingredient||DAPAGLIFLOZINE WITH METFORMINE and DAPAGLIFLOZINE|
Declarations of Xigduo® (dapagliflozine & metformine HCI) 5 mg for patients with type 2 diabetes WITHOUT a very high risk of cardiovascular disease AND who are not eligible for the pre-existing regular reimbursement of the health insurer (in combination with metformin and/or SU), with an issue from 1 July 2019 can be submitted to TBR Nederland.
Declarations of Xigduo® (dapagliflozine & metformine HCI) 5 mg for patients WITH type 2 diabetes and very high risk of cardiovascular disease, with an issue date between July 1, 2019 and September 1, 2021, have expired and can NO longer be submitted. Issues from September 1, 2021 for this group of patients will be fully reimbursed by the health insurer.
For this reimbursement scheme no closing date has been determined yet.
Patients and pharamcists can claim online and will receive the reimbursement within 5 working days.
Patients can claim by post and will receive their reimbursement within 15 working days.
Please mail the Claim Form and attachments to:
1180 LA Amstelveen
If you need any assistance please read our Frequently Asked Questions.
Still does not work? Please contact our Servicedesk via e-mail or call the Xigduo® and Forxiga® service-number 088 - 0026740
Quickly check the maximum contribution you have to pay for your medicine